Synergetics BL7600Recalls & reported problems
Synergetics USA, Inc. · Universal Viscous Fluid Control Pack · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10841305111896), received between Jan 4, 2023 and Jul 20, 2023 — classified as 2 injuries.
The most frequently reported specific device problem is “Connection Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Connection Problem1
- Detachment of Device or Device Component1
Patient problems
- Hematoma1
- Intraocular Pressure Decreased1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryJul 20, 2023Detachment of Device or Device Component; Detachment of Device or Device Component
THE USER FACILITY IN FRANCE REPORTED THAT DURING THE INJECTION OF SILICONE OIL INTO THE PATIENT'S EYE, A POPPING NOISE WAS HEARD WHICH INTERRUPTED THE SURGERY. UPON THE SURGICAL TEAM'S INSPECTION, IT WAS NOTICED THAT THE FILTER OF THE SILICONE INJECTION LINE WAS HALF MISMATCHED. THE SURGEON SUBSEQUENTLY OBSERVED A CHOROIDAL HEMATOMA EXTENDING TO 1/3 OF THE TEMPORAL SURFACE DURING THE FUNDUS EXAMINATION. A DISCHARGE SCLEROTOMY WAS PERFORMED TO ATTEMPT TO EVACUATE THE HEMATOMA, HOWEVER IT WAS WITHOUT SUCCESS. THERE WERE ALSO POTENTIALLY SIGNIFICANT CLINICAL CONSEQUENCES WITH AN ANATOMICAL AND FUNCTIONAL PROGNOSIS RESERVED. THERE WAS NO ADDITIONAL ANESTHESIA REQUIRED FOLLOWING THE ISSUE. NO ADDITIONAL MEDICAL INTERVENTION IS PLANNED TO TREAT CHOROIDAL HEMATOMA. REASSESSMENT OF THE PATIENT'S VISION CONCLUDED THAT IT HAS NOT IMPROVED COMPARED WITH VISION BEFORE THE SURGERY.
Patient problems: Hematoma
MAUDE report 17367004 ↗InjuryJan 4, 2023Connection Problem; Connection Problem
THE USER FACILITY IN SWITZERLAND REPORTED THAT THE CONNECTION TUBE CAME LOOSE SEVERAL TIMES AT THE LUER LOCK CONNECTION WITH THE OXANE SYRINGE. THE SILICONE OIL WAS INJECTED INTO THE EYE WITH MANUAL SUPPORT. THE EYE COLLAPSED AND ADDITIONAL ANESTHESIA WAS REQUIRED AS THE PROCEDURE WAS PROLONGED FOR APPROXIMATELY 10 MINUTES. THE INCIDENT DID NOT PUT THE PATIENT¿S EYE INTO PERMANENT OR TEMPORARY SERIOUS DETERIORATION OF PATIENT¿S STATE OF HEALTH AS THE SURGEON STATES THAT THE SURGERY WAS COMPLETED SUCCESSFULLY AND THERE WAS NO FURTHER REPORT OF ANY RE-OPERATION OF THE EYE, EYESIGHT DETERIORATION, BLEEDING, OR RETINAL DAMAGE DESPITE THERE WAS AN EYE COLLAPSE. THE POSSIBILITY OF RETINAL AND VITREOUS HEMORRHAGE, CHOROIDAL DETACHMENT DUE TO ACUTE HYPOTONY CANNOT BE RULED OUT DUE TO HYPOTONY CAUSED BY THE LOOSE CONNECTION (ALTHOUGH NO ADVERSE EVENTS OCCURRED).
Patient problems: Intraocular Pressure Decreased
MAUDE report 16095754 ↗
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page